AMPH: Amphastar Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,238.95
Enterprise Value ($M) 1,660.72
Book Value ($M) 751.28
Book Value / Share 15.76
Price / Book 1.65
NCAV ($M) -287.03
NCAV / Share -6.02
Price / NCAV -4.32

Profitability (mra)
Return on Invested Capital (ROIC) 0.10
Return on Assets (ROA) 0.09
Return on Equity (ROE) 0.21

Liquidity (mrq)
Quick Ratio 2.02
Current Ratio 2.95

Balance Sheet (mrq) ($M)
Current Assets 587.96
Assets 1,626.28
Liabilities 874.99
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 731.97
Operating Income 205.42
Net Income 159.52
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 213.39
Cash from Investing -124.93
Cash from Financing -80.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-07 13G/A Zhang Jack Y. 24.80 -6.78

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 49,405 283,650 17.42
2025-06-05 127,528 463,658 27.50
2025-06-04 53,339 327,745 16.27
2025-06-03 87,369 421,444 20.73
2025-06-02 101,057 537,341 18.81

(click for more detail)

Similar Companies
ALXO – ALX Oncology Holdings Inc. AMGN – Amgen Inc.
AMLX – Amylyx Pharmaceuticals, Inc. AMRX – Amneal Pharmaceuticals, Inc.
ANAB – AnaptysBio, Inc.


Financial data and stock pages provided by
Fintel.io